A $50 clone and a $500 clone sit in the same catalog here. Both carry the same documented HLVd, Fusarium, and Pythium PCR screening. So what is the other $450 for? It's a fair question, and the honest answer is narrower than most marketing would have you believe: you're paying for scarcity and pheno selection, not a better test. This post walks the actual price ladder in our catalog and shows where each tier earns its keep.
The Ladder, In Numbers
Start with the ledger. As of the September 20, 2026 inventory snapshot, our catalog holds 39 records and every one of them is marked HLVd-tested, with 19 of the 39 in stock at snapshot time. The pricing breaks into five tiers.
The $50 tier carries 11 strains, 5 of them in stock. These are the workhorses: GMO from Mau5, Biscotti OG from Beanfiendz, Chimera #3 from Littainment, Sub Zero from Grow More Fire. Lineages your propagation team already knows how to run.
The $100 tier is the widest at 14 strains, 6 in stock. Baby Cakes #11 from Solfire Gardens lives here, alongside Candy Cartel #4 from Favrd and Flo #1.
Above that the shelves thin out. Seven records sit at $250, 3 in stock: Grape Jubilee #1 from Exotic Genetix, Heavy Hustle #8, Kacklesnatch #3. Six records sit at $500, 4 in stock: Depth Charge #4 from Lovin' in Her Eyes, Pink Zkittles #1 from Hoodboys, Too Much Z, Watermelon Laterz #1, and Zero Tolerance #4 from Beanfiendz. And one record crowns the ladder at $1,000: Dante's Wrath, 54 in stock.
Every tier, same screening panel. That's the part worth saying twice.
What the Tiers Don't Price: Pheno Numbers
Here's something you can only check by staring at a real catalog. Sibling cuts of the same cross carry the same price in our book. Blueberry Gary #1 and Blueberry Gary #12, both Exotic Genetix, both $100. Kacklesnatch #3 and Kacklesnatch #4, both $250. Depth Charge #4 and Depth Charge #10, both $500.
That's deliberate. The tier prices the genetics and the cut's availability, not a ranking between sibling phenos. Each pheno is a separate record with its own stock count because a #1 and a #12 of the same cross are genuinely different plants, and we'd rather let you pick your plant than bury the difference inside a price.
So if premium doesn't buy a better test and doesn't buy a better pheno number, what's left? Scarcity of the genetics themselves. Named-breeder exotic cuts exist in limited supply. When a cut is hard to source, the price says so. That's the whole mechanism. There's no quality halo hiding behind it.
What $500 Actually Gets You
Take Zero Tolerance #4, one of our $500 records and one we get searched for constantly. Search data from our own Google Search Console shows the query "zero tolerance strain" landing on that product page 21 times in the current 28-day window at an average position of 9.52, with zero clicks, and a related query asking flat out whether Zero Tolerance is indica or sativa. People research a premium cut hard before they commit. So here's the direct answer: Zero Tolerance #4 is sativa-dominant, a Super Boof crossed with Zero Gravity out of Beanfiendz, bred for energy and focus.
That's the pattern with the top tiers generally. Depth Charge is Louisiana Leche crossed with Pure Michigan F2 out of Lovin' in Her Eyes. Pink Zkittles #1 is Trop Cherry crossed with Skittles Bomb out of Hoodboys. These are cuts with named lineages and limited availability, the kind of genetics a facility takes when it wants something competitors can't order by the thousand from a flat-price menu.
I'll admit the tradeoff plainly: scarcity pricing is not for every room. If your operation runs on proven volume genetics, the $50 tier exists for exactly that reason, and nothing about it is a consolation prize. GMO and Biscotti OG are in that tier because they earn their spot, not because they're the clearance rack.
The Entry Math at Each Tier
Run the numbers before you fall in love with a premium cut. Our per-strain minimum is 20 plants. At the $50 starting tier, a single-cultivar trial is a $1,000 commitment. At $250, it's $5,000. At the $500 tier, it's $10,000 before lights, media, or labor. At Dante's Wrath's $1,000 record price, a minimum run is $20,000, and I'd want a very specific reason to write that check, which is exactly the conversation the price is designed to start.
When does the premium make sense? When the cut's scarcity is the point: a limited pheno-hunt drop, an exotic lineage nobody nearby is running, a cultivar your brand can call its own. When does it not? When you need fifty identical plants of a proven performer on a schedule. Volume work is the $50 and $100 tiers' whole job, and the same screening stands behind them.
Flat $99 Versus a Ladder
Competitor context matters here. The Clone Foundry runs a flat $99 across its catalog, with an October promo tossing a mystery freebie into every 4-plus clone order. A flat price is simple to advertise. It also can't tell you anything about the genetics behind any individual listing, because a scarcity-priced exotic and a commodity workhorse can't honestly cost the same number. A ladder does that work out loud. You can disagree with where we've set a rung, but at least the rung is saying something.
One more flat-price caution, and this one costs people real money: whatever the price tag, ask what testing stands behind it. HLVd can run through a crop without symptoms while it drags down vigor and yield, and there is no curative treatment once it's established. Price and pathogen status are two separate questions. Never let one answer for the other.
What This Means When You Buy
Three questions to take to any clone catalog, including ours. What does the highest tier actually cost, and what justifies it? Do sibling cuts of the same cross show up as separate records with their own stock counts? And is the testing panel identical across every price point, or does the cheap tier get the cheap test?
If a premium cut fits your program, look at the current catalog to see what's in stock this week, or start a wholesale inquiry and tell us what room you're planning. If volume genetics are the mission, the $50 tier is waiting and it carries the same screening record as everything above it.
The ladder isn't a grading curve. It's an availability map, priced honestly.
This is an input-only draft for the Thursday Tier 2 fact-check process. It is not published advice, not a guarantee of rooting or yield performance, and not a substitute for local compliance review.
